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Introduction. True malignant mixed tumor, also known as carcinosarcoma, is a rare tumor of the salivary gland composed of both
malignant epithelial and malignant mesenchymal elements. Frequently carcinosarcoma arises in the background of a preexisting
pleomorphic adenoma; however, if no evidence of benignmixed tumor is present, the lesion is known as carcinosarcoma “de novo.”
We reported the first case of true malignant mixed tumor of the submandibular gland composed of high grade mucoepidermoid
carcinoma associated with osteosarcoma. Case Presentation. A 69-year-old Caucasian male came to our department complaining
of the appearance of an asymptomatic left submandibular neoformation progressively increasing in size over 3 months. We opted
for surgical treatment. Histological examination confirmed the diagnosis of carcinosarcoma with the coexistence of high grade
mucoepidermoid carcinoma and osteosarcoma. Conclusion. To the best of our knowledge, in the true malignant mixed tumor of
the submandibular gland, mucoepidermoid carcinoma associated with osteosarcoma has never been previously reported.
1. Introduction
Truemalignant mixed tumor, also known as carcinosarcoma,
is an exceedingly rare tumor of the salivary gland composed
of both malignant epithelial and malignant mesenchymal
elements. Its incidence is comprised between 0.04% and
0.16% of all salivary gland tumors with the parotid gland
being the most affected site [1–3].
The authors present a recent rare case of 69-year-old man
with a malignant mixed tumor of the left submandibular
gland consisting in the association of a mucoepidermoid
carcinoma (MEC) and an osteosarcoma. To the best of our
knowledge, in true malignant mixed tumor of the salivary
gland, these microscopic findings have never been previously
reported.
Clinical presentation and results of histological and
immunohistochemical study are reported.
2. Case Presentation
A 69-year-old Caucasian male came to our department
complaining of the appearance of an asymptomatic left
submandibular neoformation progressively increasing in size
over 3months.Medical, family, and psychosocial historywere
negative for relevant information; also, no previous surgical
treatments were reported.
On clinical examination the mass measured 8 × 5 cm
arising from level Ib (submandibular region) and extended
into levels III and IV. Such mass appeared adherent to the
underlying structures with soft texture. No pain or other
symptoms were present. Right cervical region, oropharynx,
thyroid, and upper respiratory airways showed no involve-
ment.
Ultrasound evaluation of themass revealed amixed tissue
consistency of cystic and solid areas separated by high flow
vascular fibrous septa in level Ib.
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Figure 1: Preoperative MRI, coronal T2-W: 5 × 4 × 3 cm mass
originating from the left submandibular gland. Two different multi-
lobed neoformations with colliquate areas (black square and black
trapezius) delimited by a thick pathological peripheral tissue are
clearly visible.
Contrast-enhanced magnetic resonance imaging (MRI)
of the head and neck (Figure 1) showed a 5 × 4 × 3 cm multi-
lobed neoformation originating from the left submandibular
gland. A fluid component and solid areas were inside visible.
No distant metastases were detected.
To integrate MRI data, subsequent head and neck com-
puted tomography (CT) was performed. This examination
indicated colliquate areas delimited by a thick pathological
peripheral tissue within the mass context.
First, fine-needle aspiration cytology specimen was per-
formed to determine the nature of the disease. It showed
malignant cells without distinctive features failing to identify
the type of primary lesion. A new US-FNAC was subse-
quently executed; however, also in this case the primary type
of lesion was not identified.
We opted for surgical treatment, completely removing the
mass bymeans of ipsilateral neck dissection of Ib, IIa, III, and
IV levels.
Histological examination showed a neoplastic prolifera-
tion characterized by two cellular components, substantially
distinct from each other. No fusion of the different cell types
could be seen. The first cellular component consisted of
medium size elements with multilobed nucleus and slightly
eosinophilic cytoplasm. Such elements appeared arranged in
solid cell nests with central necrosis and cribriform areas
(Figure 2). Cytokeratin and PAS positivity (Figure 3) were
evident. The second cellular component consisted of mes-
enchymal elements of medium or large size with elongated
hyperchromatic and pleomorphic nuclei. Such cellular ele-
ments appeared to be arranged around an eosinophilic mate-
rial attributable to an osteoid matrix (Figure 4). Immunohis-
tochemical study showed vimentin positivity. Tumor showed
several cellular atypia, mitoses, areas of necrosis, or bleeding
as well as angioinvasion.
Due to the coexistence of two separate cellular patterns,
both of malignant nature, a diagnosis of carcinosarcoma,
Figure 2: Mucoepidermoid carcinoma: glandular-like structure
composed of a mixture of squamous and clear cells containing
mucin (hematoxylin and eosin, 40x).
Figure 3: Some neoplastic epithelial cells with clear cytoplasm
retain PAS positivity after diastase digestion (40x).
obtained by the fusion of high grade mucoepidermoid car-
cinoma and osteosarcoma, was made.
Postoperatively, the patient underwent intensity-modu-
lated radiation with 66 Gray in 33 cycles.
At six-month follow-up no disease recurrence was
revealed.
3. Discussion
True malignant mixed tumor (carcinosarcoma) of the sali-
vary gland is an extremely rare tumor in which carcinoma-
tous and sarcomatous components coexist and metastasize
together [1–4].
Frequently, carcinosarcoma arises in the background of
a preexisting pleomorphic adenoma and, in some cases,
tumors were related to a previous history of radiotherapy.
However, if none of these conditions is present, the lesion is
classified as true malignant mixed tumor or carcinosarcoma
“de novo” [3–5]. Table 1 shows the 31 established cases of
carcinosarcoma “de novo” actually reported in the English
literature. Stephen et al. [6] in 1986 published the largest
series of true malignant mixed tumor with 12 cases of car-
cinosarcoma showed. Malignant epithelial component was
ductal carcinoma in all patients, with 1 case of squamous
component and 2 with undifferentiated features. About
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Figure 4: Osteosarcoma cells: mesenchymal elements of medium
or large size with hyperchromatic, pleomorphic, andmultinucleated
nuclei arranged around an osteoid matrix (hematoxylin and eosin,
10x).
malignant mesenchymal elements 10 chondrosarcoma and 2
mixed malignant fibrous histiocytoma cases were reported.
The most common malignant epithelial components
are squamous cell carcinoma or adenocarcinoma, whereas
the malignant mesenchymal component mainly consists of
chondrosarcoma, fibrosarcoma, or liposarcoma [1–5].
We reported the first case of true malignant mixed tumor
of the salivary gland composed of high grade mucoepider-
moid carcinoma and osteosarcoma.
Mucoepidermoid carcinoma is a common salivary tumor
derived from ductal epithelium of the salivary gland, which
displays a variety of biological behavior patterns. The high-
grade variant is more aggressive with a poor prognosis,
whereas the low-grade variant usually demonstrates satis-
factory survival rates [7]. The diagnosis of MEC includes
the identification of three intermixed tumor elements:
mucin-producing cells, intermediate and/or clear cells, and
squamoid cells [1, 7].
Osteosarcoma is the primary malignancy of bone with
rare extraosseous head and neck localizations. Typical fea-
tures of osteosarcoma are the presence of osteoid tissuewithin
the neoformation, with extremely pleomorphic cells included
in such osteoid matrix [8].
FNAC has a well-established role in the initial, preop-
erative diagnosis of salivary gland lesions. It is safe, fast,
well tolerated, and minimally invasive; however, it is known
to have several deficiencies. On average, FNAC has high
specificity (97%), but the sensitivity is somewhat lower (80%).
Thus, a positive diagnosis by FNAC is quite reliable, but
the false-negative rate associated with FNAC (20%) may be
unacceptable [9–12]. In addition, the fine-needle aspiration
cytology is not considered effective for the diagnosis of true
malignant mixed tumor [10–12]. In our case, FNAC showed
malignant cells without distinctive features failing to identify
the type of primary lesion.
Core needle biopsy (CNB) is a relatively new technique
for the diagnosis of salivary gland masses that offers several
potential advantages relative to FNAC [12, 13]. However, CNB
was not performed in our patient.
Histological and immunohistochemical studies are essen-
tial both for a correct diagnosis and for distinguishing
carcinosarcoma from other tumors. Usually, cytokeratin and
epithelial membrane antigens are positive in the carcinoma-
tous element while vimentin positivity is observed in the
sarcomatous element [1–5].
No therapeutic protocol has been established for treat-
ing this atypical disease, because of limited individual or
institutional experience. Treatment may consist of surgery
alone or surgery and postoperative radiotherapy [1, 2, 14].
Staffieri et al. [14] compared the carcinosarcoma recurrence
data in a group of patients who had undergone surgery versus
surgery plus radiotherapy, with lower recurrence rate after the
combination of surgery and radiotherapy (𝑝 = 0.3).
Due to the limited follow-up data reported in the liter-
ature, it is very difficult to comment specifically on tumor
prognosis. Moreover, the different evolution of the disease
could be explained by the histological subtypes observed.
Considering 19 cases of de novo parotid carcinosarcoma with
available data on follow-up, Staffieri et al. [14] observed that
31.6% of patients died after a median of 10.1 months from
diagnosis. Taki et al. [5] reported a case report of carci-
nosarcoma consisting of chondrosarcoma and squamous cell
carcinoma treated with total parotidectomy and radiation
therapy without local or regionally recurrent disease after 14-
month follow-up. In our case, after 6-month follow-up no
disease recurrence was revealed. However, this time is not
enough to consider a disease-free survival of our patient.
4. Conclusions
Salivary gland carcinosarcoma is a rare and highly aggressive
disease with poor prognosis. The current treatment of choice
is surgery followed by radiotherapy. However, long-term
follow-up with patients who have already undergone treat-
ment is necessary in further elucidating the clinical course of
the disease.The association in a true malignant mixed tumor
of mucoepidermoid carcinoma and osteosarcoma has never
been reported previously, representing therefore a further
possibility to be considered.
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